The Future of Pediatric Oncology: ATR Inhibition and the Evolution of Hepatoblastoma Management
ATR inhibitors offer a promising targeted therapy for high-risk hepatoblastoma, exploiting tumor replication stress to improve survival while potentially reducing cisplatin-related toxicity and long-term harm.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.